Acinetobacter baumannii y Pseudomonas aeruginosa son bacilos Gram-negativos (BGN) no fermentadores, y paradigmas de las resistencias microbianas, encontrándose dentro del grupo de microorganismos denominados ESKAPE por la Organización Mundial de la Salud (OMS) (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, A. baumannii, P....
-
February 24, 2020 (v1)PublicationUploaded on: March 27, 2023
-
January 16, 2019 (v1)Publication
Enterobacteriaceae cause different types of community- and hospital-acquired infections. Moreover, the spread of multidrug-resistant Enterobacteriaceae is a public health problem and the World Health Organization pointed them among the pathogens in which the search of new antibiotics is critical. The objective of this study was to analyze the...
Uploaded on: December 5, 2022 -
June 7, 2018 (v1)Publication
Despite the relevance of carbapenemase-producing Klebsiella pneumoniae (CP-Kp) infections there are a scarce number of studies to evaluate in vivo the efficacy of combinations therapies. The bactericidal activity of colistin, rifampin, and its combination was studied (time-kill curves) against four clonally unrelated clinical isolates of CP-Kp,...
Uploaded on: March 27, 2023 -
February 11, 2021 (v1)Publication
Multidrug-resistant (MDR) Pseudomonas aeruginosa is a public health problem causing both community and hospital-acquired infections, and thus the development of new therapies for these infections is critical. The objective of this study was to analyze in vitro the activity of pentamidine as adjuvant in combinations to antibiotics against seven...
Uploaded on: December 4, 2022 -
May 8, 2023 (v1)Publication
We evaluated the efficacy of ceftazidime or colistin in combi nation with polyclonal IgM-enriched immunoglobulin (IgM-IG), in an experimental pneumonia model (C57BL/6J male mice) using two multidrug-resistant Pseudomonas aeruginosa strains, both ceftazidime-susceptible and one colistin-resistant. Pharmaco dynamically optimised antimicrobials...
Uploaded on: May 10, 2023 -
April 28, 2023 (v1)Publication
In the context of difficult-to-treat carbapenem-resistant Pseudomonas aeruginosa infections, we evaluated imipenem, meropenem, and doripenem combinations against eleven carbapenemase-producing P. aeruginosa isolates. According to the widespread global distribution of high-risk clones and carbapenemases, four representative isolates were...
Uploaded on: April 29, 2023 -
July 12, 2022 (v1)Publication
Carbapenemase-producing Klebsiella pneumoniae infections are an increasing global threat with scarce and uncertain treatment options. In this context, combination therapies are often used for these infections. The bactericidal and synergistic activity of fosfomycin plus amikacin and gentamicin was studied trough time–kill assays against four...
Uploaded on: March 24, 2023 -
April 29, 2020 (v1)Publication
Background: S. pneumoniae is the leading cause of community-acquired pneumonia in the solid organ transplant recipient (SOTR); nevertheless, the prevalence of colonization and of the colonizing/infecting serotypes has not been studied in this population. In this context, the aim of the present study was to describe the rate, characteristics,...
Uploaded on: March 27, 2023